XORTX Pharma careers

XORTX is a therapeutics company spun out from the University of Florida, with a fast track strategy to licensing and market approval. Initially targeting the orphan disease markets, we are developing safer therapies to treat major and rare kidney diseases caused by improper uric acid metabolism. Uric acid is an essential molecule necessary for excretion of excess nutrients. However, at chronically high levels, serum uric acid (SUA) acts through a newly discovered mechanism to cause disease. XORTX is focusing on new applications of selected drug products that treat rare diseases like autosomal dominant polycystic kidney disease (ADPKD) and lifestyle diseases like metabolic syndrome, diabetes and diabetic nephropathy, which had previously not been associated with high SUA. XORTX has secured intellectual property and experienced key personnel to exploit the therapeutic potential of drugs to decrease SUA levels. Orphan programs are attractive due to market exclusivity and price benefits.